论文部分内容阅读
不管是否已知患糖尿病,AMI病人入院时糖代谢状态都是长期死亡率的一项重要指标。确定没有诊断糖尿病的AMI病人中糖代谢异常的发病率究竟有多高,便于早期进行干预,改善结果。对象与方法 1998年11月1日至2000年12月15日收入瑞典Karolinska和Vasteras医院CCU病房疑有AMI的181例病人为研究对象,病人基线血糖浓度都<11.1mmol/L。入院后第1d早晨测量了HbA_(1c),每天测量空腹血糖直到出院,出院时(第4d第5d)做标准的口服葡萄糖(75g)耐量试验(OGTT),出院3个月后再次测量HbA_(1c)、空腹血糖和OGTT。根据WHO1998年的规定和美国糖尿病协会的标准,空腹血糖
Irrespective of whether diabetes is known, the status of glucose metabolism at AMI is an important indicator of long-term mortality. Determine how high the prevalence of abnormal glucose metabolism is in AMI patients without diabetes, facilitating early intervention and improving outcomes. Subjects and Methods From November 1, 1998 to December 15, 2000, 181 patients with suspected AMI in the CCU ward of Sweden’s Karolinska and Vasteras hospitals were included in the study. All patients had baseline blood glucose concentrations <11.1 mmol / L. HbA_ (1c) was measured on the morning of the first day after admission, the fasting blood glucose was measured every day until discharged, and the standard oral glucose (75g) tolerance test (OGTT) was performed at discharge (5th day of the 4th day) 1c), fasting blood glucose and OGTT. Fasting blood glucose was measured according to WHO’s 1998 regulations and the National Association for the Study of the American Society for Diabetes